Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin–piperine for Pseudomonas infection in cystic fibrosis
IRCT20221229056976N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Mar 2023
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of curcumin and piperine in cystic fibrosis (CF) and Pseudomonal infection, sponsored by Mashhad University of Medical Sciences. Started Mar 2023; status: completed.
02
Drugs
curcuminpiperine
03
Conditions
cystic fibrosis (CF)Pseudomonal infection
Beyond the preview
Go deeper on IRCT20221229056976N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221229056976N1.